NUTX vs THC

For growth investors, Nutex Health, Inc.

(NUTX) is the stronger pick with 82. 4% revenue growth year-over-year, versus 3. 1% for Tenet Healthcare Corporation (THC). Tenet Healthcare Corporation (THC) offers the better valuation at 12. 5x trailing P/E (10. 9x forward), making it the more compelling value choice. Analysts rate Nutex Health, Inc. (NUTX) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Tenet Healthcare Corporation (THC) is the cheapest at 12.

5x versus Nutex Health, Inc. at 12. 8x. On forward P/E, Nutex Health, Inc. is actually cheaper at 8. 7x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Tenet Healthcare Corporation (THC) delivered a total return of +190.

4%, compared to -97. 8% for Nutex Health, Inc. (NUTX). Over 10 years, the gap is even starker: THC returned +523. 4% versus NUTX's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Tenet Healthcare Corporation (THC) is the lower-risk stock at 0.

71β versus Nutex Health, Inc. 's 2. 01β — meaning NUTX is approximately 184% more volatile than THC relative to the S&P 500. On balance sheet safety, Nutex Health, Inc. (NUTX) carries a lower debt/equity ratio of 83% versus 147% for Tenet Healthcare Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Nutex Health, Inc.

(NUTX) is pulling ahead at 82. 4% versus 3. 1% for Tenet Healthcare Corporation (THC). On earnings-per-share growth, the picture is similar: Nutex Health, Inc. grew EPS 7. 9% year-over-year, compared to -52. 6% for Tenet Healthcare Corporation. Over a 3-year CAGR, NUTX leads at 58. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Nutex Health, Inc.

(NUTX) is the more profitable company, earning 8. 1% net margin versus 6. 6% for Tenet Healthcare Corporation — meaning it keeps 8. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NUTX leads at 31. 5% versus 16. 1% for THC. At the gross margin level — before operating expenses — THC leads at 82. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Nutex Health, Inc.

(NUTX) trades at 8. 7x forward P/E versus 10. 9x for Tenet Healthcare Corporation — 2. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NUTX: 52. 3% to $205. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Tenet Healthcare Corporation (THC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

71), +523. 4% 10Y return). Nutex Health, Inc. (NUTX) carries a higher beta of 2. 01 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (THC: +523. 4%, NUTX: -97. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NUTX is a small-cap high-growth stock; THC is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.